Diagnosis and initial management of acute HIV infection

American Family Physician

Volumn 81, Issue 10, 2010, Pages 1239-1244

  Chu, Carolyn ^a   Selwyn, Peter A ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPYRETIC AGENT; ANTIRETROVIRUS AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; VIRUS ANTIBODY; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACUTE DISEASE; ANOREXIA; ANTIBODY DETECTION; ANTIBODY TITER; ARTHRALGIA; ARTICLE; CLINICAL FEATURE; DIARRHEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LYMPHADENOPATHY; MACULOPAPULAR RASH; MYALGIA; PATIENT EDUCATION; PHARYNGITIS; POPULATION RISK; RASH; SAFE SEX; SKIN ULCER; VIRUS LOAD; WESTERN BLOTTING; DIFFERENTIAL DIAGNOSIS; PRIMARY HEALTH CARE; REVIEW; SERODIAGNOSIS;

AIDS SERODIAGNOSIS; ANTI-HIV AGENTS; DIAGNOSIS, DIFFERENTIAL; HIV INFECTIONS; HUMANS; PRIMARY HEALTH CARE;

EID: 77953473225     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Coco A, Kleinhans E. Prevalence of primary HIV infection in symptomatic ambulatory patients. Ann Fam Med. 2005;3(5):400-404.
2. Daar ES, Pilcher CD, Hecht FM. Clinical presentation and diagnosis of primary HIV-1 infection. Curr Opin HIV AIDS. 2008;3(1):10-15.
3. Taiwo BO, Hicks CB. Primary human immunodeficiency virus. South Med J. 2002;95(11):1312-1317.
4. Perlmutter BL, Glaser JB, Oyugi SO. How to recognize and treat acute HIV syndrome [published correction appears in Am Fam Physician. 2000;61(2):308]. Am Fam Physician. 1999;60(2):535-542, 545-546.
5. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States and dependent areas, 2007. HIV/AIDS surveillance report, volume 19. http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2007report/. Accessed July 1, 2009.
6. Lavreys L, Thompson ML, Martin HL Jr, et al. Primary human immunodeficiency virus type 1 infection: clinical manifestations among women in Mombasa, Kenya. Clin Infect Dis. 2000;30(3):486-490.
7. Schacker T, et al. Clinical and epidemiologic features of primary HIV infection [published correction appears in Ann Intern Med. 1997;126(2):174]. Ann Intern Med. 1996;125(4):257-264.
8. Hecht FM, Busch MP, Rawal B, et al. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS. 2002;16(8):1119-1129.
9. Daar ES, Little S, Pitt J, et al. Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network. Ann Intern Med. 2001; 134(1):25-29.
10. Vanhems P, Hughes J, Collier AC, et al. Comparison of clinical features, CD4 and CD8 responses among patients with acute HIV-1 infection from Geneva, Seattle and Sydney. AIDS. 2000;14(4):375-381.
11. Douvoyiannis M, Litman N. Acute encephalopathy and multi-organ involvement with rhabdomyolysis during primary HIV infection. Int J Infect Dis. 2009;13(5): e299-e304.
12. Manata MJ, Melo AZ, Quaresma MJ. Esophageal candidiasis in acute HIV infection. Presented at: International Conference on AIDS; August 7-12, 1994; Lisbon, Portugal. Abstract PB0593.
13. Miller WC, Leone PA, McCoy S, Nguyen TQ, Williams DE, Pilcher CD. Targeted testing for acute HIV infection in North Carolina. AIDS. 2009;23(7):835-843.
14. Powers KA, Miller WC, Pilcher CD, et al.; Malawi UNC Project Acute HIV Study Team. Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm. AIDS. 2007;21(16):2237-2242.
15. Busch MP, Satten GA. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am J Med. 1997;102(5B):117-124.
16. Pantaleo G, Graziosi C, Fauci AS. New concepts in the immunopathogenesis of human immunodeficiency virus infection. N Engl J Med. 1993;328(5):327-335.
17. Weber B, Orazi B, Raineri A, et al. Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi. Clin Lab. 2006;52(9-10):463-473.
18. Rich JD, Merriman NA, Mylonakis E, et al. Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series. Ann Intern Med. 1999;130(1):37-39.
19. Chou R, Huffman LH, Fu R, Smits AK, Korthuis PT. Screening for HIV: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2005;143(1):55-73.
20. Centers for Disease Control (CDC). Update: serologic testing for HIV-1 antibody-United States, 1988 and 1989. MMWR Morb Mortal Wkly Rep. 1990;39(22):380-383.
21. Lee CC, Sun YJ, Barkham T, Leo YS. Primary drug resistance and transmission analysis of HIV-1 in acute and recent drug-naïve seroconverters in Singapore. HIV Med. 2009;10(6):370-377.
22. Brenner BG, Roger M, Routy JP, et al.; Quebec Primary HIV Infection Study Group. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis. 2007;195(7):951-959.
23. Incorporating HIV prevention into the medical care of persons living with HIV. Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America [published correction appears in MMWR Recomm Rep. 2004;53(32):744]. MMWR Recomm Rep. 2003;52(RR-12):1-24.
24. Healthy Living Project Team. Effects of a behavioral intervention to reduce risk of transmission among people living with HIV: the healthy living project randomized controlled study. J Acquir Immune Defic Syndr. 2007;44(2):213-221.
25. Xia Q, Molitor F, Osmond DH, et al. Knowledge of sexual partner's HIV serostatus and serosorting practices in a California population-based sample of men who have sex with men. AIDS. 2006;20(16):2081-2089.
26. Tambussi G, Gori A, Capiluppi B, et al. Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid. Clin Infect Dis. 2000;30(6):962-965.
27. Aberg JA, Gallant JE, Anderson J, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2004;39(5):609-629.
28. Truong HM, et al. Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance. AIDS. 2006;20(17):2193-2197.
29. Hirsch MS, Brun-Vézinet F, D'Aquila RT, et al. Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. JAMA. 2000;283(18):2417-2426.
30. Landon BE, et al. Physician specialization and the quality of care for human immunodeficiency virus infection. Arch Intern Med. 2005;165(10):1133-1139.
31. Landon BE, Wilson IB, Cohn SE, et al. Physician specialization and antiretroviral therapy for HIV. J Gen Intern Med. 2003;18(4):233-241.
32. Kelley CF, Barbour JD, Hecht FM. The relation between symptoms, viral load, and viral load set point in primary HIV infection. J Acquir Immune Defic Syndr. 2007;45(4):445-448.
33. Streeck H, Jolin JS, Qi Y, et al. Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells. J Virol. 2009;83(15):7641-7648.
34. Burgers WA, et al.; CAPRISA 002 Acute Infection Study Team. Association of HIV-specific and total CD8+ T memory phenotypes in subtype C HIV-1 infection with viral set point. J Immunol. 2009;182(8):4751-4761.
35. Oxenius A, Price DA, Easterbrook PJ, et al. Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. Proc Natl Acad Sci USA. 2000;97(7):3382-3387.
36. Koopman JS, et al. The role of early HIV infection in the spread of HIV through populations. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14(3):249-258.
37. Pantazis N, et al.; CASCADE Collaboration. The effect of antiretroviral treatment of different durations in primary HIV infection. AIDS. 2008;22(18):2441-2450.
38. Voirin N, et al. Effect of early initiation of highly active antiretroviral therapy on CD4 cell count and HIV-RNA viral load trends within 24 months of the onset of acute retroviral syndrome. HIV Med. 2008;9(6):440-444.
39. Hecht FM, Wang L, Collier A, et al.; AIEDRP Network. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis. 2006;194(6):725-733.
40. Smith DE, et al. Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence? AIDS. 2004;18(5):709-718.